LEADER 03947nam  22006135  450 
001 9910863298503321
005 20251113173733.0
010   $a9789811575907
010   $a9811575908
024 7 $a10.1007/978-981-15-7590-7
035   $a(CKB)4100000011515526
035   $a(DE-He213)978-981-15-7590-7
035   $a(MiAaPQ)EBC6381074
035   $a(PPN)258064404
035   $a(EXLCZ)994100000011515526
100   $a20201021d2020      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCompetitive Strategies in Life Sciences /$fby Basanta Kumara Behera, Ram Prasad, Shyambhavee Behera
205   $a1st ed. 2020.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2020.
215   $a1 online resource (XV, 189 p. 84 illus., 56 illus. in color.)
225 1 $aNew Paradigms of Living Systems,$x2662-3498 ;$v1
311 08$a9789811575891 
311 08$a9811575894 
327   $aChapter 1. Strategies in Life sciences -- Chapter 2. Management and Manufacturing process of biologics -- Chapter 3. Downstream processes -- Chapter 4. Bioprinting  -- Chapter 5. Biopharmaceuticals: New Frontier.
330   $aTailoring of biomolecules using protein engineering technology, and host cells culture techniques are among the most sophisticated and elegant achievements of modern applied life sciences in which the basic fundamentals biotechnology are applicable for the development and manufacturing of biologics and other related bio-molecules for a hurdle free life with good health. A majority of biologics derived from genetically modified host cells in the current market are bio-formulation such as antibodies, nucleic acid products and vaccines. Such bio-formulations are developed mainly in two steps i.e. upstream process and downstream process. The first volume of this series begins with the latest information on how the classical stepwise host cells culture (mammals, animals, plants, and bacteria) methodology has been changed to fully continuous or partially continuous host cells culture process in order to economise the biopharmaceutical products manufacturing process. In addition this volume narrates a brief history on conceptual development of new thoughts in designing biotechnology industries for commercial production of variety of therapeutic proteins with structural modification on the basis of clinical requirements. The readers will feel exited by going through the latest discovery and development in applied life sciences for designing innovative biomolecules for health care with utmost safe. The most interesting part of this volume is newly developed concept on bioprinting. It explains how to design and fabricate animate objects by fusing or depositing material of interest in the form of powders, solid dusts, metal, liquid or even living cells or tissues by layers to produce 3D objectives. The first volume ends with the latest information on the current trend in biologics market, market dynamic, drives, and opportunities with challenges.
410  0$aNew Paradigms of Living Systems,$x2662-3498 ;$v1
606   $aBiomaterials
606   $aNucleic acids
606   $aBioinformatics
606   $aBiology$xTechnique
606   $aNucleic Acid
606   $aComputational and Systems Biology
606   $aBiological Techniques
615  0$aBiomaterials.
615  0$aNucleic acids.
615  0$aBioinformatics.
615  0$aBiology$xTechnique.
615 14$aNucleic Acid.
615 24$aComputational and Systems Biology.
615 24$aBiological Techniques.
676   $a574.19283
700   $aBehera$b Basanta Kumara$0947396
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910863298503321
996   $aCompetitive strategies in life sciences$92513672
997   $aUNINA